Funding · Company
Avenzo Therapeutics, Inc.
San Diego, CABiotech & Pharma
Avenzo Therapeutics, Inc. of San Diego, CA has disclosed $433M across 2 Form D offerings filed with the SEC between Nov 20, 2024 and Sep 5, 2025.
$433M
Total disclosed
2
Form D offerings
2022
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$47M
Form D · Sep 5, 2025 ↗
Q3 2025
· target $75M
$386M
Form D · Nov 20, 2024 ↗
Q4 2024
· 2 amendments, first filed Sep 29, 2022
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2022SEC CIK0001947742Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →